XJPX
3937
Market cap85mUSD
Oct 09, Last price
1,146.00JPY
1D
2.78%
1Q
14.60%
Jan 2017
56.24%
IPO
20.63%
Name
Ubicom Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ubicom Holdings, Inc., established in Tokyo, Japan in 2005, delivers comprehensive information technology (IT) solutions primarily within Japan and across Asia. The company's diverse offerings encompass application development and testing, embedded software, and quality assurance, alongside advanced services in artificial intelligence, data analytics, and various automation technologies, including Robotic Process Automation (RPA). Beyond general IT, Ubicom specializes in medical IT solutions for hospitals and clinics. These include support for receipt processing, medical safety, data analysis, cloud services, development assistance, and consulting, all designed to navigate shifts in medical systems and mitigate labor shortages. The corporation adopted its current name, Ubicom Holdings, Inc., in July 2017, having previously been known as AWS Holdings, Inc.
Key people
Katsumi Murayama
Senior Executive Officer · since 2024
Naoki Takahashi
Senior Executive Officer, Director of R&D Transformation Strategy in Main Technology Consulting Business Unit · since 2024
Naoko Noguchi
Executive Officer, Chief Financial Officer, Senior Director of Finance and Accounting, Senior Director of General Affairs and Human Resources · since 2025
Shingo Chiba
Executive Officer · since 2024
Yasutaka Kawakita
Executive Officer · since 2024
Kazuhide Miyoshi
Executive Officer · since 2025
Vincent Remo
Executive Officer, Director of Overseas Operations Strategy in Main Technology Consulting Business Unit · since 2024
Peter Tan
Executive Officer, Director of AI Strategy Business in Main Technology Consulting Business Unit · since 2024
Nanju Zen
Executive Officer, Director of Transformation Strategy Business in Main Technology Consulting Business Unit · since 2025
Masayuki Aoki
President, Chief Executive Officer, Chairman and President of Subsidiary, Representative Director · since 2023
Akisato Kitaoka
Senior Executive Officer, Chief Director of Medical Business, Chief Director of Corporate Strategy, Manager of Business Planning Office, Director · since 2024
Yoshinori Hashitani
Independent Director · since 2019
Natsumi Horikawa
Independent Director · since 2025
Toshiyuki Ito
Independent Director · since 2019
Independent Director · since 2023
Taisuke Tsuyuguchi
Independent Director · since 2025
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||